<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2026 Workiva-->
<!--r:019e6a7f-3a2c-7e30-acc1-d5ae4ae8f1fc,g:0d1f2584-f555-42ce-b27a-904151cd021c-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="https://xbrl.org/2023/arcrole/summation-item" xlink:type="simple" xlink:href="https://www.xbrl.org/2023/calculation-1.1.xsd#summation-item"/>
  <link:roleRef roleURI="http://vtvtherapeutics.com/role/CondensedConsolidatedBalanceSheets" xlink:type="simple" xlink:href="vtvt-20260630.xsd#CondensedConsolidatedBalanceSheets"/>
  <link:calculationLink xlink:role="http://vtvtherapeutics.com/role/CondensedConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_019e6a7f-3af5-741d-b425-e6ea65efac67" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_019e6a7f-3af5-7f54-bdab-bb2d2e873267" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_019e6a7f-3af5-741d-b425-e6ea65efac67" xlink:to="loc_us-gaap_AssetsCurrent_019e6a7f-3af5-7f54-bdab-bb2d2e873267" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_019e6a7f-3af5-7cd4-9b3f-1c727d961f1b" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_019e6a7f-3af5-741d-b425-e6ea65efac67" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_019e6a7f-3af5-7cd4-9b3f-1c727d961f1b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_019e6a7f-3af5-71ed-a880-c2326f16fca6" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_019e6a7f-3af5-7e58-a6f4-a17133ca0e2b" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_019e6a7f-3af5-71ed-a880-c2326f16fca6" xlink:to="loc_us-gaap_LiabilitiesCurrent_019e6a7f-3af5-7e58-a6f4-a17133ca0e2b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtvt_WarrantyLiability_019e6a7f-3af5-7e5d-8120-f6bd329253bd" xlink:href="vtvt-20260630.xsd#vtvt_WarrantyLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_019e6a7f-3af5-71ed-a880-c2326f16fca6" xlink:to="loc_vtvt_WarrantyLiability_019e6a7f-3af5-7e5d-8120-f6bd329253bd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_019e6a7f-3af5-72d4-9d15-1f19a328b362" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_019e6a7f-3af5-71ed-a880-c2326f16fca6" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_019e6a7f-3af5-72d4-9d15-1f19a328b362" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_019e6a7f-3af5-7cfc-89f1-171c36091bd9" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_019e6a7f-3af5-789e-b37f-3b9540d037a6" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_019e6a7f-3af5-7cfc-89f1-171c36091bd9" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_019e6a7f-3af5-789e-b37f-3b9540d037a6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtvt_WarrantLiabilityCurrent_019e6a7f-3af5-7a4d-b23a-6371e9f7b452" xlink:href="vtvt-20260630.xsd#vtvt_WarrantLiabilityCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_019e6a7f-3af5-7cfc-89f1-171c36091bd9" xlink:to="loc_vtvt_WarrantLiabilityCurrent_019e6a7f-3af5-7a4d-b23a-6371e9f7b452" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_019e6a7f-3af5-7c09-9160-d4f97ffd271a" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_019e6a7f-3af5-7bd9-98b0-014b1c783c3b" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_019e6a7f-3af5-7c09-9160-d4f97ffd271a" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_019e6a7f-3af5-7bd9-98b0-014b1c783c3b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_019e6a7f-3af5-7a68-a53a-40f0259e15da" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_019e6a7f-3af5-7c09-9160-d4f97ffd271a" xlink:to="loc_us-gaap_CommonStockValue_019e6a7f-3af5-7a68-a53a-40f0259e15da" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_019e6a7f-3af5-70ab-9fb1-b1a38eeeb8af" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_019e6a7f-3af5-7c09-9160-d4f97ffd271a" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_019e6a7f-3af5-70ab-9fb1-b1a38eeeb8af" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_019e6a7f-3af5-711f-b7f9-7a94da57cc98" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_019e6a7f-3af5-7187-8098-b66ce9afaf4b" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_019e6a7f-3af5-711f-b7f9-7a94da57cc98" xlink:to="loc_us-gaap_OtherAssetsCurrent_019e6a7f-3af5-7187-8098-b66ce9afaf4b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent_019e6a7f-3af5-7e6c-af08-c8e5ddfee113" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_019e6a7f-3af5-711f-b7f9-7a94da57cc98" xlink:to="loc_us-gaap_PrepaidExpenseCurrent_019e6a7f-3af5-7e6c-af08-c8e5ddfee113" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_019e6a7f-3af5-7335-bdcc-1e22bc7355ac" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_019e6a7f-3af5-711f-b7f9-7a94da57cc98" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_019e6a7f-3af5-7335-bdcc-1e22bc7355ac" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_019e6a7f-3af5-72cf-a1f7-8c48643d9869" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_019e6a7f-3af5-74d7-90f7-a3258b39873b" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_019e6a7f-3af5-72cf-a1f7-8c48643d9869" xlink:to="loc_us-gaap_Liabilities_019e6a7f-3af5-74d7-90f7-a3258b39873b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_019e6a7f-3af5-7c1a-bde4-c66b6b6c27a7" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_019e6a7f-3af5-72cf-a1f7-8c48643d9869" xlink:to="loc_us-gaap_CommitmentsAndContingencies_019e6a7f-3af5-7c1a-bde4-c66b6b6c27a7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_019e6a7f-3af5-7e90-a7e6-3190ab992019" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_019e6a7f-3af5-72cf-a1f7-8c48643d9869" xlink:to="loc_us-gaap_StockholdersEquity_019e6a7f-3af5-7e90-a7e6-3190ab992019" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://vtvtherapeutics.com/role/CondensedConsolidatedStatementsofOperationsUnaudited" xlink:type="simple" xlink:href="vtvt-20260630.xsd#CondensedConsolidatedStatementsofOperationsUnaudited"/>
  <link:calculationLink xlink:role="http://vtvtherapeutics.com/role/CondensedConsolidatedStatementsofOperationsUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_019e6a7f-3af5-7e27-a629-09b795fa74c3" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_019e6a7f-3af5-7835-8bfb-cd2f31300199" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_019e6a7f-3af5-7e27-a629-09b795fa74c3" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_019e6a7f-3af5-7835-8bfb-cd2f31300199" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_019e6a7f-3af5-77ee-abd8-5e76009f0c84" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_019e6a7f-3af5-7e27-a629-09b795fa74c3" xlink:to="loc_us-gaap_OperatingExpenses_019e6a7f-3af5-77ee-abd8-5e76009f0c84" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_019e6a7f-3af5-712d-b815-48d12bda4880" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_019e6a7f-3af5-7358-bf50-aec9bc1ff385" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_019e6a7f-3af5-712d-b815-48d12bda4880" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_019e6a7f-3af5-7358-bf50-aec9bc1ff385" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_019e6a7f-3af5-7577-98e6-4935e43d0d5e" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_019e6a7f-3af5-712d-b815-48d12bda4880" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_019e6a7f-3af5-7577-98e6-4935e43d0d5e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_019e6a7f-3af5-7fb3-933b-279b9651c8b4" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_019e6a7f-3af5-72fa-88ea-ae8f07a17286" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_019e6a7f-3af5-7fb3-933b-279b9651c8b4" xlink:to="loc_us-gaap_ProfitLoss_019e6a7f-3af5-72fa-88ea-ae8f07a17286" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_019e6a7f-3af5-7d97-9883-57a325da1b2d" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_019e6a7f-3af5-7fb3-933b-279b9651c8b4" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_019e6a7f-3af5-7d97-9883-57a325da1b2d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_019e6a7f-3af5-76e2-a278-7d8221cd01a0" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_019e6a7f-3af5-7205-9042-6deb51942aed" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_019e6a7f-3af5-76e2-a278-7d8221cd01a0" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_019e6a7f-3af5-7205-9042-6deb51942aed" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_019e6a7f-3af5-715a-81eb-e861b7b43e75" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_019e6a7f-3af5-76e2-a278-7d8221cd01a0" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_019e6a7f-3af5-715a-81eb-e861b7b43e75" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_019e6a7f-3af5-7116-ac0c-cf6554d54325" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_019e6a7f-3af5-7236-b946-66c78fbf3bbd" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_019e6a7f-3af5-7116-ac0c-cf6554d54325" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_019e6a7f-3af5-7236-b946-66c78fbf3bbd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_019e6a7f-3af5-708d-be24-091cea5881d5" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_019e6a7f-3af5-7116-ac0c-cf6554d54325" xlink:to="loc_us-gaap_InvestmentIncomeInterest_019e6a7f-3af5-708d-be24-091cea5881d5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_019e6a7f-3af5-7c7f-8311-04092f6365b3" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_019e6a7f-3af5-7116-ac0c-cf6554d54325" xlink:to="loc_us-gaap_OperatingIncomeLoss_019e6a7f-3af5-7c7f-8311-04092f6365b3" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://vtvtherapeutics.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" xlink:type="simple" xlink:href="vtvt-20260630.xsd#CondensedConsolidatedStatementsofCashFlowsUnaudited"/>
  <link:calculationLink xlink:role="http://vtvtherapeutics.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019e6a7f-3af5-778a-8b53-1464a843b633" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_019e6a7f-3af5-7bf1-9ebf-ecc72ed586ec" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019e6a7f-3af5-778a-8b53-1464a843b633" xlink:to="loc_us-gaap_ProfitLoss_019e6a7f-3af5-7bf1-9ebf-ecc72ed586ec" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_019e6a7f-3af5-718e-9f39-02e97f45b19c" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_Depreciation"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019e6a7f-3af5-778a-8b53-1464a843b633" xlink:to="loc_us-gaap_Depreciation_019e6a7f-3af5-718e-9f39-02e97f45b19c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_019e6a7f-3af5-7ab1-95aa-59e13fe9cf97" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019e6a7f-3af5-778a-8b53-1464a843b633" xlink:to="loc_us-gaap_ShareBasedCompensation_019e6a7f-3af5-7ab1-95aa-59e13fe9cf97" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAdjustmentOfWarrants_019e6a7f-3af5-7731-a180-75295598724b" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_FairValueAdjustmentOfWarrants"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019e6a7f-3af5-778a-8b53-1464a843b633" xlink:to="loc_us-gaap_FairValueAdjustmentOfWarrants_019e6a7f-3af5-7731-a180-75295598724b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_019e6a7f-3af5-7453-8486-8b6b4ad755e8" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019e6a7f-3af5-778a-8b53-1464a843b633" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_019e6a7f-3af5-7453-8486-8b6b4ad755e8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherCurrentAssets_019e6a7f-3af5-7cf0-906f-8754ac010e3f" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncreaseDecreaseInOtherCurrentAssets"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019e6a7f-3af5-778a-8b53-1464a843b633" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherCurrentAssets_019e6a7f-3af5-7cf0-906f-8754ac010e3f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_019e6a7f-3af5-71b0-8e5d-d531d68c0959" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019e6a7f-3af5-778a-8b53-1464a843b633" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_019e6a7f-3af5-71b0-8e5d-d531d68c0959" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_019e6a7f-3af5-702f-85eb-078f9d69703e" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019e6a7f-3af5-778a-8b53-1464a843b633" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_019e6a7f-3af5-702f-85eb-078f9d69703e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_019e6a7f-3af5-7443-82d2-6e6f4b5036b5" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019e6a7f-3af5-778a-8b53-1464a843b633" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_019e6a7f-3af5-7443-82d2-6e6f4b5036b5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_019e6a7f-3af5-743c-8370-b4d0aa52fc14" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019e6a7f-3af5-778a-8b53-1464a843b633" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_019e6a7f-3af5-743c-8370-b4d0aa52fc14" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_019e6a7f-3af5-7d92-9ffd-b57b97e3d915" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019fb194-6668-7562-9d19-8cf9fdad94ef" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_019e6a7f-3af5-7d92-9ffd-b57b97e3d915" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019fb194-6668-7562-9d19-8cf9fdad94ef" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019e6a7f-3af5-70fc-a014-054101d556ad" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_019e6a7f-3af5-7d92-9ffd-b57b97e3d915" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019e6a7f-3af5-70fc-a014-054101d556ad" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019f69c8-57f5-79dd-a1c5-dcb41b8e54d1" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_019f69c8-57f5-7627-afd5-d2160b3fee75" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019f69c8-57f5-79dd-a1c5-dcb41b8e54d1" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_019f69c8-57f5-7627-afd5-d2160b3fee75" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_019f69c8-57f5-70ea-8de3-cea90014a65d" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019f69c8-57f5-79dd-a1c5-dcb41b8e54d1" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_019f69c8-57f5-70ea-8de3-cea90014a65d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://vtvtherapeutics.com/role/SegmentInformationScheduleofSegmentReportingInformationbySegmentDetails" xlink:type="simple" xlink:href="vtvt-20260630.xsd#SegmentInformationScheduleofSegmentReportingInformationbySegmentDetails"/>
  <link:calculationLink xlink:role="http://vtvtherapeutics.com/role/SegmentInformationScheduleofSegmentReportingInformationbySegmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_019e6a7f-3bcc-75d7-bd95-6459fbaa729f" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtvt_DirectResearchAndDevelopmentExpense_019e6a7f-3bcc-70e9-84ac-4e70e670aad8" xlink:href="vtvt-20260630.xsd#vtvt_DirectResearchAndDevelopmentExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense_019e6a7f-3bcc-75d7-bd95-6459fbaa729f" xlink:to="loc_vtvt_DirectResearchAndDevelopmentExpense_019e6a7f-3bcc-70e9-84ac-4e70e670aad8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtvt_IndirectResearchDevelopmentExpense_019e6a7f-3bcc-7dc8-aaa0-451cd92e1d1a" xlink:href="vtvt-20260630.xsd#vtvt_IndirectResearchDevelopmentExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense_019e6a7f-3bcc-75d7-bd95-6459fbaa729f" xlink:to="loc_vtvt_IndirectResearchDevelopmentExpense_019e6a7f-3bcc-7dc8-aaa0-451cd92e1d1a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://vtvtherapeutics.com/role/NetLossIncomeperShareScheduleofReconciliationoftheNumeratorandDenominatorUsedintheCalculationofBasicandDilutedNetIncomeLossperShareofClassACommonStockDetails" xlink:type="simple" xlink:href="vtvt-20260630.xsd#NetLossIncomeperShareScheduleofReconciliationoftheNumeratorandDenominatorUsedintheCalculationofBasicandDilutedNetIncomeLossperShareofClassACommonStockDetails"/>
  <link:calculationLink xlink:role="http://vtvtherapeutics.com/role/NetLossIncomeperShareScheduleofReconciliationoftheNumeratorandDenominatorUsedintheCalculationofBasicandDilutedNetIncomeLossperShareofClassACommonStockDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_019e6a7f-3bcc-7bae-a0d1-613d2cb982f9" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_019e6a7f-3bcc-7d07-8a8d-ab9ad3560e50" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_019e6a7f-3bcc-7bae-a0d1-613d2cb982f9" xlink:to="loc_us-gaap_ProfitLoss_019e6a7f-3bcc-7d07-8a8d-ab9ad3560e50" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_019e6a7f-3bcc-74b5-8195-fd1d58479293" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_019e6a7f-3bcc-7bae-a0d1-613d2cb982f9" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_019e6a7f-3bcc-74b5-8195-fd1d58479293" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_019e6a7f-3bcc-72d7-9098-95f1b8d5b36f" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_019e6a7f-3bcc-7ec3-a2b9-bca0be65614e" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_019e6a7f-3bcc-72d7-9098-95f1b8d5b36f" xlink:to="loc_us-gaap_ProfitLoss_019e6a7f-3bcc-7ec3-a2b9-bca0be65614e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_019e6a7f-3bcc-73b9-a312-bcc39df95abe" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_019e6a7f-3bcc-72d7-9098-95f1b8d5b36f" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_019e6a7f-3bcc-73b9-a312-bcc39df95abe" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
